The indication for treating breast cancer with chemotherapy is generally based on clinical and tumorbiological characteristics such as lymph node involvement, hormone receptor status, and Her-2/neu expression, which are indicators of prognosis but do not necessarily indicate likelihood of response. This evidence concerns the gene NR4A1 and breast carcinoma.